As people with prostates (PwP) get older, they are more likely to have prostatic conditions such as BPH, prostatitis, and prostate cancer. Screening for prostate cancer can be considered using the prostate-specific antigen (PSA) test alone, or in conjunction with a digital rectal exam (in which the clinician uses a finger through the rectum to feel for prostate growths)—guidelines vary. Per the Canadian Urological Association in 2022, the recommended age to consider starting for prostate cancer screening is around 50 years of age for those who are at average risk. However, it is recommended that those at higher risk, including African, Caribbean, and Black (ACB) men, consider screening for prostate cancer earlier at age 45.
Everything you need to know about PrEP: Slide Deck & FAQ
Pre-exposure prophylaxis (PrEP) for 2SGBTQ men: Everything you need to know about PrEP
The GMSH has developed a downloadable slide deck on pre-exposure prophylaxis (PrEP). This primer contains data and research which give a useful rundown of much of the science around PrEP for HIV prevention.
The primer includes information on:
• What is PrEP?
• How PrEP works to prevent HIV infection?
• Side effects & contraindications of PrEP
• PrEP research studies and outcomes
• Kidney, eGFR, and bone health
• PrEP dosing for cis and trans persons
• Stigma of PrEP use
• STIs and testing when on PrEP
• Cost for PrEP
There is also an FAQ on PrEP which complements the Power Point slides to provide more information to users on various terms and definition, research studies on PrEP, medical and clinical reports, information on medications, kidney functions, drug interactions, and references on PrEP.
These slides and FAQ are intended for front-line, outreach staff, public health workers, and others providing sexual health care to the communities of Two-Spirit, gay, bisexual, trans, and queer (2SGBTQ) men, as well as other men who have sex with men (MSM).
The information on PrEP is provided for informational or educational purposes only. The resource on PrEP is not a substitute for professional medical advice, diagnosis, or treatment. Always speak to your healthcare provider for further information on PrEP use.
For questions, please contact: dnambiar@gmsh.ca